Nanochon
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $10M
Investors
- 8
About Nanochon
Established in 2016 by CEO Ben Holmes and CTO Nathan Castro, and based in the District of Columbia, US, Nanochon, Inc. engages in the research and development of the Chondrograft, a 3-D cartilage implant surgical technique used to cure illnesses and joint replacement. In January 2026, Nanochon, Inc. Nanochon addresses the need for effective cartilage repair, especially for younger, active patients. Its flagship product, Chondrograft, uses 3D printing and nanomaterials to create a minimally invasive implant that replaces damaged cartilage and encourages new tissue growth. By mimicking natural cartilage and supporting stem cell attachment, Chondrograft offers a cost-effective, off-the-shelf solution with significantly reduced recovery times compared to traditional joint replacements.
Who invested in Nanochon
8 investors across 4 rounds
See all investors in Nanochon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nanochon
Who invested in Nanochon?
Nanochon has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanochon raised?
Nanochon has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Nanochon last raise money?
Nanochon's most recent round on record is a Seed, in Jan 2026.
What does Nanochon do?
Established in 2016 by CEO Ben Holmes and CTO Nathan Castro, and based in the District of Columbia, US, Nanochon, Inc.
Where is Nanochon headquartered?
Nanochon is headquartered in Washington, US.
Which VCs invest in companies like Nanochon?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nanochon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Nanochon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.